^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

yttrium Y 90 tabituximab barzuxetan (OTSA101-DTPA-90Y)

i
Other names: OTSA101, OTSA101-DTPA, OTSA101-DTPA-90Y, Frizzled homologue 10 antibodies, Anti-Frizzled Homolog 10 Monoclonal Antibody, FZD10
Associations
Trials
Company:
OncoTherapy
Drug class:
Wnt signalling pathway inhibitor
Associations
Trials